Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sona Nanotech Inc C.SONA

Alternate Symbol(s):  SNANF

Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use in multiplex diagnostic testing platforms and advanced biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of cetyltrimethylammonium bromide (CTAB), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company is focused on the development of a pre-clinical nanomedical therapy for the treatment of cancer using its biocompatible GNR.


CSE:SONA - Post by User

Bullboard Posts
Post by wintraderon Jul 30, 2020 10:10am
179 Views
Post# 31343003

Repost : SONA on Path to a Billion Dollar Valuation

Repost : SONA on Path to a Billion Dollar Valuation

Sona Nanotech – On Path To A Billion Dollar Valuation

Whether you are a new investor or a seasoned investor with many years of experience, both share the same goal, to find that one stock that will deliver unprecedented returns on their investment and change one’s life. Sona Nanotech has been and continues to be the stock that is enriching shareholders!

Sona Nanotech (CSE: SONA) (OTCQB: SNANF) is a great Canadian life sciences company and a true investment darling that has gripped the investing community by storm as SONA soared to a high of $16.05 on July 28th 2020 considering it was only a mere $.13 cents in January. Once SONA hits $16.45, it will have reached a $1 billion valuation! Although the term “Unicorn” is meant for private start-up companies who reach a $1 Billion valuation, we think SONA is an exception to the rule, as SONA is a little unicorn in the making on the CSE! 

Sona Nanotech has developed a rapid screening antigen testing unit for Covid-19 and SONA’s antigen test is able to detect whether a patient is infected with Covid-19 in approximately 10-15 mins with 96% accuracy. SONA received validation results indicating the efficacy of its antigen testing on July 2nd 2020 This is a huge leap forward in an age of testing for Covid-19, as other methods such as nasal testing can take up to a week to know the results if a patient is indeed infected with Coronavirus.

On July 8th 2020SONA announced that the company has engaged Maxim Group LLC, a full service investments banking firm to assist SONA in the process of up listing the company’s US listed shares to the Nasdaq, a significant upgrade from the OTC market where its shares currently trade under the symbol (SNANF) on the OTCQB. The planned move to up-list its shares from the Over-The-Counter market to the Nasdaq is a big move for the company and its investors as the move to the big board will position the company to attract serious investors as well as large funds in the United States. Darren Rowles the CEO of SONA stated "Sona Nanotech has achieved the extraordinary by bringing a COVID-19 rapid, point-of-care antigen test to fruition in four months with an extremely focused team in the laboratory. The change provides me with the opportunity to focus on my passion for science and driving innovation through the company. I'm delighted to welcome David to Sona's leadership team and continuing the partnership with him to capitalize on the efforts made to get these unique tests authorized, manufactured and in to as many hands as possible around the world”. SONA is working with Maxim Group LLC to pursue its path to the Nasdaq, however there are regulatory requirements the company must meet and is subject to approval by the exchange.

Sona Nanotech Hits 3,047 Since Our Alert!

We first highlighted SONA as one of our top Coronavirus stocks back on March 16th 2020, in our article titled “2 Coronavirus Stocks to Watch” when shares of SONA were trading at $.51 cents per share. Since our alert, shares of SONA have roared to a high of $16.05, marking a hefty 3,047% in ROI since our alert! We put SONA as our top coronavirus stock due its good share structure, strong management team and its innovative rapid testing technology which we knew could serve a large market and have a large positive impact in our future of living with Covid-19.


The end of the coronavirus is not so clear as rates of infection continue to increase around the world and a vaccine for the Coronavirus only available in 18 months or so, which, even that isn’t a guarantee. With this being said, rapid testing will continue to be a major factor as communities, cities and countries begin to reopen, and with the need to test people for coronavirus around the world, we believe SONA’s rapid antigen test will play a vital role in future testing and this will provide SONA with large revenues in the near future. 

Investors must note that although SONA has had a wild run the last couple of months, we believe shares of SONA will continue to increase as the company receives approval from the FDA and Health Canada for its rapid test, and in addition, the listing to the Nasdaq exchange. Be on the look out for more news from SONA as it may send the stock soaring past $20.00 very soon!


Bullboard Posts